BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 29213627)

  • 1. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
    de Paula VJR; Guimarães FM; Diniz BS; Forlenza OV
    Dement Neuropsychol; 2009; 3(3):188-194. PubMed ID: 29213627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR; Härtig W; Schober R
    J Hirnforsch; 1998; 39(2):175-81. PubMed ID: 10022341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.
    Tiwari SS; Mizuno K; Ghosh A; Aziz W; Troakes C; Daoud J; Golash V; Noble W; Hortobágyi T; Giese KP
    Brain; 2016 Oct; 139(Pt 10):2751-2765. PubMed ID: 27524794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling function in Alzheimer's disease.
    De Ferrari GV; Inestrosa NC
    Brain Res Brain Res Rev; 2000 Aug; 33(1):1-12. PubMed ID: 10967351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF Biomarkers for Alzheimer's Disease Diagnosis.
    Anoop A; Singh PK; Jacob RS; Maji SK
    Int J Alzheimers Dis; 2010 Jun; 2010():. PubMed ID: 20721349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
    Wang H; Liu X; Chen S; Ye K
    Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qualitative and quantitative differences in senile plaque dystrophic neurites of Alzheimer's disease and normal aged brain.
    Wang D; Munoz DG
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):548-56. PubMed ID: 7602328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria.
    Nagy Z; Esiri MM; Jobst KA; Morris JH; King EM; McDonald B; Litchfield S; Smith A; Barnetson L; Smith AD
    Dementia; 1995; 6(1):21-31. PubMed ID: 7728216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathology of the neuronal cytoskeleton in Alzheimer's disease.
    Brion JP
    Biochim Biophys Acta; 1992 Nov; 1160(1):134-42. PubMed ID: 1384716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.